Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2025-12-24 @ 5:13 PM
Study NCT ID:
NCT03894150
Status:
COMPLETED
Last Update Posted:
2024-05-14
First Post:
2019-03-26
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.
Sponsor:
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-11
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-12
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-26
First Submit QC Date:
None
Study First Post Date:
2019-03-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-12
Last Update Post Date:
2024-05-14
Last Update Post Date Type:
ACTUAL